These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 17439980)

  • 1. A novel progranulin mutation associated with variable clinical presentation and tau, TDP43 and alpha-synuclein pathology.
    Leverenz JB; Yu CE; Montine TJ; Steinbart E; Bekris LM; Zabetian C; Kwong LK; Lee VM; Schellenberg GD; Bird TD
    Brain; 2007 May; 130(Pt 5):1360-74. PubMed ID: 17439980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TDP-43 pathology in familial frontotemporal dementia and motor neuron disease without Progranulin mutations.
    Seelaar H; Schelhaas HJ; Azmani A; Küsters B; Rosso S; Majoor-Krakauer D; de Rijk MC; Rizzu P; ten Brummelhuis M; van Doorn PA; Kamphorst W; Willemsen R; van Swieten JC
    Brain; 2007 May; 130(Pt 5):1375-85. PubMed ID: 17360763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic correlation in PGRN mutations.
    Davion S; Johnson N; Weintraub S; Mesulam MM; Engberg A; Mishra M; Baker M; Adamson J; Hutton M; Rademakers R; Bigio EH
    Neurology; 2007 Sep; 69(11):1113-21. PubMed ID: 17522386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia.
    van Swieten JC; Heutink P
    Lancet Neurol; 2008 Oct; 7(10):965-74. PubMed ID: 18771956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series.
    Beck J; Rohrer JD; Campbell T; Isaacs A; Morrison KE; Goodall EF; Warrington EK; Stevens J; Revesz T; Holton J; Al-Sarraj S; King A; Scahill R; Warren JD; Fox NC; Rossor MN; Collinge J; Mead S
    Brain; 2008 Mar; 131(Pt 3):706-20. PubMed ID: 18234697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathological changes underlying frontotemporal lobar degeneration with clinicopathological correlation.
    Shi J; Shaw CL; Du Plessis D; Richardson AM; Bailey KL; Julien C; Stopford C; Thompson J; Varma A; Craufurd D; Tian J; Pickering-Brown S; Neary D; Snowden JS; Mann DM
    Acta Neuropathol; 2005 Nov; 110(5):501-12. PubMed ID: 16222525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study.
    Le Ber I; Camuzat A; Hannequin D; Pasquier F; Guedj E; Rovelet-Lecrux A; Hahn-Barma V; van der Zee J; Clot F; Bakchine S; Puel M; Ghanim M; Lacomblez L; Mikol J; Deramecourt V; Lejeune P; de la Sayette V; Belliard S; Vercelletto M; Meyrignac C; Van Broeckhoven C; Lambert JC; Verpillat P; Campion D; Habert MO; Dubois B; Brice A;
    Brain; 2008 Mar; 131(Pt 3):732-46. PubMed ID: 18245784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene.
    Mackenzie IR; Baker M; Pickering-Brown S; Hsiung GY; Lindholm C; Dwosh E; Gass J; Cannon A; Rademakers R; Hutton M; Feldman HH
    Brain; 2006 Nov; 129(Pt 11):3081-90. PubMed ID: 17071926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations.
    Josephs KA; Ahmed Z; Katsuse O; Parisi JF; Boeve BF; Knopman DS; Petersen RC; Davies P; Duara R; Graff-Radford NR; Uitti RJ; Rademakers R; Adamson J; Baker M; Hutton ML; Dickson DW
    J Neuropathol Exp Neurol; 2007 Feb; 66(2):142-51. PubMed ID: 17278999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of novel progranulin (GRN) mutations in frontotemporal dementia.
    Mukherjee O; Wang J; Gitcho M; Chakraverty S; Taylor-Reinwald L; Shears S; Kauwe JS; Norton J; Levitch D; Bigio EH; Hatanpaa KJ; White CL; Morris JC; Cairns NJ; Goate A
    Hum Mutat; 2008 Apr; 29(4):512-21. PubMed ID: 18183624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial frontotemporal dementia: a report of three cases of severe cerebral atrophy with rare inclusions that are negative for tau and synuclein, but positive for ubiquitin.
    Chang HT; Cortez S; Vonsattel JP; Stopa EG; Schelper RL
    Acta Neuropathol; 2004 Jul; 108(1):10-6. PubMed ID: 15108011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extrapyramidal features in patients with motor neuron disease and dementia; a clinicopathological correlative study.
    Mackenzie IR; Feldman H
    Acta Neuropathol; 2004 Apr; 107(4):336-40. PubMed ID: 14745570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The genetic and pathological classification of familial frontotemporal dementia.
    Morris HR; Khan MN; Janssen JC; Brown JM; Perez-Tur J; Baker M; Ozansoy M; Hardy J; Hutton M; Wood NW; Lees AJ; Revesz T; Lantos P; Rossor MN
    Arch Neurol; 2001 Nov; 58(11):1813-6. PubMed ID: 11708988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubiquitin-positive neuronal and tau 2-positive glial inclusions in frontotemporal dementia of motor neuron type.
    Forno LS; Langston JW; Herrick MK; Wilson JD; Murayama S
    Acta Neuropathol; 2002 Jun; 103(6):599-606. PubMed ID: 12012092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 17q-linked frontotemporal dementia-amyotrophic lateral sclerosis without tau mutations with tau and alpha-synuclein inclusions.
    Wilhelmsen KC; Forman MS; Rosen HJ; Alving LI; Goldman J; Feiger J; Lee JV; Segall SK; Kramer JH; Lomen-Hoerth C; Rankin KP; Johnson J; Feiler HS; Weiner MW; Lee VM; Trojanowski JQ; Miller BL
    Arch Neurol; 2004 Mar; 61(3):398-406. PubMed ID: 15023818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary Pick's disease with the G272V tau mutation shows predominant three-repeat tau pathology.
    Bronner IF; ter Meulen BC; Azmani A; Severijnen LA; Willemsen R; Kamphorst W; Ravid R; Heutink P; van Swieten JC
    Brain; 2005 Nov; 128(Pt 11):2645-53. PubMed ID: 16014652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The unexpected co-occurrence of GRN and MAPT p.A152T in Basque families: Clinical and pathological characteristics.
    Moreno F; Indakoetxea B; Barandiaran M; Caballero MC; Gorostidi A; Calafell F; Gabilondo A; Tainta M; Zulaica M; Martí Massó JF; López de Munain A; Sánchez-Juan P; Lee SE
    PLoS One; 2017; 12(6):e0178093. PubMed ID: 28594853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, neuropathological, and genetic characteristics of the novel IVS9+1delG GRN mutation in a patient with frontotemporal dementia.
    Taipa R; Tuna A; Damásio J; Pinto PS; Cavaco S; Pereira S; Milterberger-Miltenyi G; Galimberti D; Melo-Pires M
    J Alzheimers Dis; 2012; 30(1):83-90. PubMed ID: 22366770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions.
    Simón-Sánchez J; Dopper EG; Cohn-Hokke PE; Hukema RK; Nicolaou N; Seelaar H; de Graaf JR; de Koning I; van Schoor NM; Deeg DJ; Smits M; Raaphorst J; van den Berg LH; Schelhaas HJ; De Die-Smulders CE; Majoor-Krakauer D; Rozemuller AJ; Willemsen R; Pijnenburg YA; Heutink P; van Swieten JC
    Brain; 2012 Mar; 135(Pt 3):723-35. PubMed ID: 22300876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration.
    Yu CE; Bird TD; Bekris LM; Montine TJ; Leverenz JB; Steinbart E; Galloway NM; Feldman H; Woltjer R; Miller CA; Wood EM; Grossman M; McCluskey L; Clark CM; Neumann M; Danek A; Galasko DR; Arnold SE; Chen-Plotkin A; Karydas A; Miller BL; Trojanowski JQ; Lee VM; Schellenberg GD; Van Deerlin VM
    Arch Neurol; 2010 Feb; 67(2):161-70. PubMed ID: 20142524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.